Literature DB >> 17162275

Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.

Altan Onat1, Gülay Hergenç, Hüseyin Uyarel, Günay Can, Hakan Ozhan.   

Abstract

OBJECTIVES: To investigate prospectively the incidence, certain predictors and outcomes of type 2 diabetes (DM), as well as to determine its prevalence cross-sectionally, in a representative sample of Turkish men and women.
METHODS: Prospective evaluation of 3401 male and female participants (aged 48.2 +/-12 years). Follow-up constituted 19,050 person-years. Individuals with DM were diagnosed with criteria of the American Diabetes Association. Fatal and nonfatal coronary heart disease (CHD) was identified by clinical findings and Minnesota coding of resting electrocardiograms. Cut-points of > or = 95 cm in males and > or = 91 cm in females were selected for abdominal obesity. For prospective evaluations, cases with DM or CHD were excluded.
RESULTS: Prevalence of DM in Turkish adults was estimated as 2.89 million (11.0% of the population aged > or = 35 years). Over a mean follow-up of 5.9 years, incident DM developed in 223 subjects, yielding an incidence per 1000 person-years of 11.0 in women and 12.4 in men. This corresponded to a 300,000 annual incidence. Following risk parameter levels but not HDL-cholesterol were significantly elevated at baseline in subjects developing DM compared to those without: age (5 years), waist girth (7 cm), blood pressure (12/6 mmHg), apolipoprotein B (7 mg/dl), total cholesterol (14 mg/dl), and fasting triglycerides (only in women, 52 mg/dl). Abdominal obesity (RR 2.61 [95%CI 1.87; 3.63]) and age in both genders, hypertension (RR 1.81 [95%CI 1.10; 2.98]) and low HDL-cholesterol in men alone were significant independent predictors of DM. Diabetes mellitus was a significant and independent predictor of fatal and nonfatal CHD, with a RR of 1.81 (95%CI 1.19; 2.75), after adjustment for sex, age, hypertension, waist circumference, serum total cholesterol and smoking status.
CONCLUSIONS: The annual incidence of DM in Turkey rises very rapidly, currently stands at 300,000, and, hence, its prevalence also rises correspondingly. Insulin resistance appears to be a weak determinant of DM in Turkish women while abdominal obesity is the main determinant. Multivariately adjusted DM is a significant independent predictor of fatal and nonfatal CHD. These observations emphasize that measures to reverse or stop the "epidemic" of abdominal obesity are severely required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17162275

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  17 in total

1.  Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study.

Authors:  Mohsen Janghorbani; Masoud Amini; Ashraf Aminorroaya
Journal:  Rev Diabet Stud       Date:  2016-08-10

2.  High prevalence of diabetes in elderly of Iran: an urgent public health issue.

Authors:  Farid Fotouhi; Farhad Rezvan; Hassan Hashemi; Ali Javaherforoushzadeh; Mirgholamreza Mahbod; Abbasali Yekta; Zahra Jamshididana; Mehdi Khabazkhoob
Journal:  J Diabetes Metab Disord       Date:  2022-05-19

3.  Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.

Authors:  Vicki L Ellingrod; Del D Miller; Stephan F Taylor; Jessica Moline; Timothy Holman; Jane Kerr
Journal:  Schizophr Res       Date:  2007-10-31       Impact factor: 4.939

4.  Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women.

Authors:  Farzad Hadaegh; Masumeh Hatami; Maryam Tohidi; Parvin Sarbakhsh; Navid Saadat; Feridoun Azizi
Journal:  Lipids Health Dis       Date:  2010-08-17       Impact factor: 3.876

5.  Dynamics in Cardiometabolic Risk among Turkish Adults: Similarities to that in Iranians?

Authors:  Altan Onat
Journal:  Int J Prev Med       Date:  2011-04

6.  Validation of the Turkish version of the Centre for Epidemiologic Studies Depression Scale (CES-D) in patients with type 2 diabetes mellitus.

Authors:  Vicky Lehmann; Ceylan Makine; Cagatay Karşıdağ; Pinar Kadıoğlu; Kubilay Karşıdağ; François Pouwer
Journal:  BMC Med Res Methodol       Date:  2011-07-26       Impact factor: 4.615

7.  A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.

Authors:  Gültekin Süleymanlar; Cengiz Utaş; Turgay Arinsoy; Kenan Ateş; Bülent Altun; Mehmet Riza Altiparmak; Tevfik Ecder; Mehmet Emin Yilmaz; Taner Çamsari; Ali Başçi; Ali Riza Odabas; Kamil Serdengeçti
Journal:  Nephrol Dial Transplant       Date:  2010-11-04       Impact factor: 5.992

8.  Establishment of Health Clinics as Mass Screening and Referral Systems for Chronic Non-communicable Diseases in Primary Health Care.

Authors:  Kamal Heidari; Sayyed Ali Sajjadi; Rezvaneh Hadian; Somayeh Hadi; Ramesh Hosseinkhani; Soudabeh Amini; Zahra Kiani; Ali Ajami; Reza Fadaei; Anahita Shahriari; Kasra Keramatian
Journal:  Int J Prev Med       Date:  2012-03

9.  Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults.

Authors:  Ilhan Satman; Beyhan Omer; Yildiz Tutuncu; Sibel Kalaca; Selda Gedik; Nevin Dinccag; Kubilay Karsidag; Sema Genc; Aysegul Telci; Bulent Canbaz; Fulya Turker; Temel Yilmaz; Bekir Cakir; Jaakko Tuomilehto
Journal:  Eur J Epidemiol       Date:  2013-02-14       Impact factor: 8.082

10.  Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia.

Authors:  Alireza Esteghamati; Alipasha Meysamie; Omid Khalilzadeh; Armin Rashidi; Mehrdad Haghazali; Fereshteh Asgari; Mandana Kamgar; Mohammad Mehdi Gouya; Mehrshad Abbasi
Journal:  BMC Public Health       Date:  2009-05-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.